18 studies found for:    Open Studies | "Gallbladder Neoplasms"
Show Display Options
Rank Status Study
1 Not yet recruiting Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery
Conditions: Hepatocellular Carcinoma;   Hepatoma;   Cholangiocarcinoma;   Gallbladder Neoplasms
Interventions: Drug: Sevoflurane;   Drug: Desflurane
2 Unknown  Tomotherapy in Locally Advanced Gallbladder and Pancreatic Cancers
Condition: Gallbladder Neoplasms and Pancreatic Neoplasms
Intervention: Radiation: Tomotherapy
3 Recruiting ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Adenocarcinoma of the Gallbladder;   Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Gallbladder;   Duct Cell Adenocarcinoma of the Pancreas;   Localized Unresectable Adult Primary Liver Cancer;   Periampullary Adenocarcinoma;   Recurrent Adult Primary Liver Cancer;   Recurrent Gallbladder Cancer;   Recurrent Pancreatic Cancer;   Stage II Gallbladder Cancer;   Stage III Pancreatic Cancer;   Stage IIIA Gallbladder Cancer;   Stage IIIB Gallbladder Cancer;   Stage IV Pancreatic Cancer;   Stage IVA Gallbladder Cancer;   Stage IVB Gallbladder Cancer
Interventions: Drug: ADH-1;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis
4 Recruiting Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer
Conditions: Cholangiocarcinoma;   Gallbladder Carcinoma;   Biliary Carcinoma
Intervention: Drug: Gemcitabine-Pazopanib
5 Recruiting Permission to Collect Blood Over Time for Research
Conditions: Pancreatic Cancer;   Gastrointestinal Neoplasms;   Colon Rectal Cancer Adenocarcinoma;   Esophageal Cancer;   Gall Bladder Cancer;   Gastric (Stomach) Cancer;   Gastrooesophageal Cancer;   Gastrointestinal Stromal Tumor (GIST);   Hepatobiliary Neoplasm;   Liver Carcinoma;   Gallbladder Carcinoma;   Bile Duct Carcinoma;   Carcinoma of the Large Intestine;   Anal Cancer
Intervention: Procedure: Observation
6 Recruiting Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers
Conditions: Biliary Tract Cancer;   Gallbladder Cancer;   Cholangiocarcinoma;   Ampullary Cancer
Interventions: Other: Active Symptom Control;   Drug: L-folinic acid;   Drug: 5 FU;   Drug: Oxaliplatin
7 Recruiting Storage of Bile From Routine Procedures to Study Risk Factors
Conditions: Gallbladder Cancer;   Cholangiocarcinoma;   Biliary Tract Cancer
Intervention:
8 Recruiting Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed By Surgery
Conditions: Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Extrahepatic Bile Duct Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Childhood Liver Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Recurrent Gallbladder Cancer;   Stage C Adult Primary Liver Cancer (BCLC);   Stage D Adult Primary Liver Cancer (BCLC);   Stage II Gallbladder Cancer;   Stage III Childhood Liver Cancer;   Stage IIIA Gallbladder Cancer;   Stage IIIB Gallbladder Cancer;   Stage IV Childhood Liver Cancer;   Stage IVA Gallbladder Cancer;   Stage IVB Gallbladder Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Interventions: Drug: trametinib;   Drug: leucovorin calcium;   Drug: fluorouracil;   Drug: capecitabine;   Other: laboratory biomarker analysis
9 Recruiting A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC
Conditions: Cholangiocarcinoma;   Adenocarcinoma of Gallbladder
Interventions: Drug: gemcitabine, oxaliplatin;   Drug: cetuximab, gemcitabine, oxaliplatin
10 Not yet recruiting A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer
Conditions: Biliary Tract Carcinoma;   Gallbladder Carcinoma
Interventions: Drug: MEK 162;   Drug: Gemcitabine;   Drug: Oxaliplatin
11 Recruiting Initial Study of Gallbladder Cancer in Chile
Conditions: Gallbaldder Cancer;   Gallstones
Intervention:
12 Unknown  HAI Via Interventionally Implanted Port Catheter Systems
Conditions: Colorectal Cancer;   Liver Neoplasms;   Hepatocellular Carcinoma;   Gallbladder Cancer;   Bile Duct Cancer
Intervention: Device: interventionally implanted hepatic arterial port catheter
13 Recruiting Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Lung Cancer;   Melanoma;   Non-Hodgkin's Lymphoma;   Uterine Cancer;   CORPUS UTERI,ENDOMETRIUM;   LUNG;   OVARY
Intervention:
14 Unknown  A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer
Conditions: Gallbladder Cancer;   Bile Duct Cancer
Intervention: Drug: Fluorouracil implant
15 Recruiting Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Liver Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: oxaliplatin;   Other: clinical observation;   Procedure: adjuvant therapy;   Procedure: quality-of-life assessment
16 Not yet recruiting A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
Conditions: Biliary Tract Carcinoma;   Gallbladder Carcinoma
Interventions: Drug: Selumetinib;   Drug: Cisplatin;   Drug: Gemcitabine
17 Recruiting Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Biliary Tract Cancer
Conditions: Cholangiocarcinoma;   Gall Bladder Carcinoma
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Other: Observation
18 Recruiting Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Adenocarcinoma of the Gallbladder;   Adenocarcinoma of Unknown Primary;   Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Diffuse Adenocarcinoma of the Stomach;   Duct Cell Adenocarcinoma of the Pancreas;   Intestinal Adenocarcinoma of the Stomach;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Carcinoma of Unknown Primary;   Metastatic Extrahepatic Bile Duct Cancer;   Mixed Adenocarcinoma of the Stomach;   Mucinous Adenocarcinoma of the Colon;   Mucinous Adenocarcinoma of the Rectum;   Newly Diagnosed Carcinoma of Unknown Primary;   Signet Ring Adenocarcinoma of the Colon;   Signet Ring Adenocarcinoma of the Rectum;   Stage III Pancreatic Cancer;   Stage IIIA Colon Cancer;   Stage IIIA Gallbladder Cancer;   Stage IIIA Gastric Cancer;   Stage IIIA Rectal Cancer;   Stage IIIB Colon Cancer;   Stage IIIB Gallbladder Cancer;   Stage IIIB Gastric Cancer;   Stage IIIB Rectal Cancer;   Stage IIIC Colon Cancer;   Stage IIIC Gastric Cancer;   Stage IIIC Rectal Cancer;   Stage IV Gastric Cancer;   Stage IV Pancreatic Cancer;   Stage IVA Colon Cancer;   Stage IVA Gallbladder Cancer;   Stage IVA Rectal Cancer;   Stage IVB Colon Cancer;   Stage IVB Gallbladder Cancer;   Stage IVB Rectal Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Interventions: Drug: oxaliplatin;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: fluorouracil;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years